These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27324843)

  • 1. Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.
    Bhatt H; Gamboa CM; Safford MM; Soliman EZ; Glasser SP
    J Am Soc Hypertens; 2016 Jul; 10(7):578-586.e5. PubMed ID: 27324843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of hypertension severity and control with risk of incident atrial fibrillation: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Garg PK; Wilson N; Yuan Y; Howard VJ; Judd S; Howard G; Soliman EZ
    Clin Cardiol; 2023 Nov; 46(11):1418-1425. PubMed ID: 37605862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study.
    Bhatt H; Gamboa CM; Safford MM; Soliman EZ; Glasser SP
    J Am Soc Hypertens; 2016 Sep; 10(9):702-713.e4. PubMed ID: 27461397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Duration and Degree of Hypertension and Body Weight on New-Onset Atrial Fibrillation: A Nationwide Population-Based Study.
    Kim YG; Han KD; Choi JI; Yung Boo K; Kim DY; Oh SK; Lee KN; Shim J; Kim JS; Kim YH
    Hypertension; 2019 Nov; 74(5):e45-e51. PubMed ID: 31522617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
    J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Hypertension and Systolic Blood Pressure With the Risk of Stroke or Bleeding in Patients With Atrial Fibrillation: The Fushimi AF Registry.
    Ishii M; Ogawa H; Unoki T; An Y; Iguchi M; Masunaga N; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M
    Am J Hypertens; 2017 Nov; 30(11):1073-1082. PubMed ID: 28575205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, Sex, Age, and Regional Differences in the Association of Obstructive Sleep Apnea With Atrial Fibrillation: Reasons for Geographic and Racial Differences in Stroke Study.
    Ghazi L; Bennett A; Petrov ME; Howard VJ; Safford MM; Soliman EZ; Glasser SP
    J Clin Sleep Med; 2018 Sep; 14(9):1485-1493. PubMed ID: 30176963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
    Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
    Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study.
    Ghazi L; Safford MM; Khodneva Y; O'Neal WT; Soliman EZ; Glasser SP
    J Am Soc Hypertens; 2016 Aug; 10(8):625-632.e1. PubMed ID: 27350188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data.
    Jafari E; Cooper-DeHoff RM; Effron MB; Hogan WR; McDonough CW
    Am J Hypertens; 2024 Jan; 37(1):60-68. PubMed ID: 37712350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Tanner RM; Chaudary N; Colantonio LD; Merriman TR; Reynolds RJ; Bridges SL; Cushman M; Saag K; Limdi N; Muntner P; Howard G; Irvin MR
    J Hypertens; 2023 Jun; 41(6):1033-1039. PubMed ID: 37016935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.
    Irvin MR; Shimbo D; Mann DM; Reynolds K; Krousel-Wood M; Limdi NA; Lackland DT; Calhoun DA; Oparil S; Muntner P
    J Clin Hypertens (Greenwich); 2012 Oct; 14(10):694-700. PubMed ID: 23031147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Baber U; Howard VJ; Halperin JL; Soliman EZ; Zhang X; McClellan W; Warnock DG; Muntner P
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):26-32. PubMed ID: 21076159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
    Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
    Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study.
    Sampson UK; Edwards TL; Jahangir E; Munro H; Wariboko M; Wassef MG; Fazio S; Mensah GA; Kabagambe EK; Blot WJ; Lipworth L
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):33-54. PubMed ID: 24365671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
    Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
    Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
    Langford AT; Akinyelure OP; Moore TL; Howard G; Min YI; Hillegass WB; Bress AP; Tajeu GS; Butler M; Jaeger BC; Yano Y; Shimbo D; Ogedegbe G; Calhoun D; Booth JN; Muntner P
    Hypertension; 2020 Nov; 76(5):1600-1607. PubMed ID: 32924633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
    Akinyelure OP; Jaeger BC; Safford MM; Oparil S; Carson AP; Sims A; Hannon L; Howard G; Muntner P; Hardy ST
    J Am Heart Assoc; 2024 May; 13(10):e031695. PubMed ID: 38752519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.